Cardiovascular and Hematological Agents in Medicinal Chemistry This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Anti-angiogenic Potential of Trans-chalcone in an In Vivo Chick Chorioallantoic Membrane Model: An ATP Antagonist to VEGFR with Predicted Blood-brain Barrier Permeability
CONCLUSION: The present study showed TC to possess anti-angiogenic potential via the inhibition of VEGFR-2. In addition, the study predicted TC to cross BBB as well as a safe alternative for GBM therapy, which needs further investigation.PMID:37936455 | DOI:10.2174/0118715257250417231019102501 (Source: Cardiovascular and Hematological Agents in Medicinal Chemistry)
Source: Cardiovascular and Hematological Agents in Medicinal Chemistry - November 8, 2023 Category: Cardiology Authors: Anna Senrung Tanya Tripathi Nikita Aggarwal Divya Janjua Arun Chhokar Joni Yadav Apoorva Chaudhary Kulbhushan Thakur Tejveer Singh Alok Chandra Bharti Source Type: research
Combined Administration of Metformin and Vitamin D: A Futuristic Approach for Management of Hyperglycemia
Cardiovasc Hematol Agents Med Chem. 2023 Oct 27. doi: 10.2174/0118715257261643231018102928. Online ahead of print.ABSTRACTDiabetes is a series of metabolic disorders that can be categorized into three types depending on different aspects associated with age at onset, intensity of insulin resistance, and beta- cell dysfunction: Type 1 and 2 Diabetes, and Gestational Diabetes Mellitus. Type 2 Diabetes Mellitus (T2DM) has recently been found to account for more than 85% of diabetic cases. The current review intends to raise awareness among clinicians/researchers that combining vitamin D3 with metformin may pave the way for be...
Source: Cardiovascular and Hematological Agents in Medicinal Chemistry - November 6, 2023 Category: Cardiology Authors: Sakshi Tyagi Shalini Mani Source Type: research